Infectious Disease Drugs Market, Global Outlook and Forecast 2023-2028

Report ID: 1568829 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Infectious Disease Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Infectious Disease Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Infectious Disease Drugs Overall Market Size
    2.1 Global Infectious Disease Drugs Market Size: 2021 VS 2028
    2.2 Global Infectious Disease Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Infectious Disease Drugs Players in Global Market
    3.2 Top Global Infectious Disease Drugs Companies Ranked by Revenue
    3.3 Global Infectious Disease Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Infectious Disease Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Infectious Disease Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Infectious Disease Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Infectious Disease Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Infectious Disease Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Infectious Disease Drugs Market Size Markets, 2021 & 2028
        4.1.2 Antibacterials
        4.1.3 Antiviral drugs
        4.1.4 Antiparasitic drugs
        4.1.5 Antifungal
        4.1.6 Others
    4.2 By Type - Global Infectious Disease Drugs Revenue & Forecasts
        4.2.1 By Type - Global Infectious Disease Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Infectious Disease Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Infectious Disease Drugs Market Size, 2021 & 2028
        5.1.2 HIV
        5.1.3 Malaria
        5.1.4 Hepatitis
        5.1.5 Influenza
        5.1.6 HPV
        5.1.7 Tuberculosis
        5.1.8 Others
    5.2 By Application - Global Infectious Disease Drugs Revenue & Forecasts
        5.2.1 By Application - Global Infectious Disease Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Infectious Disease Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Infectious Disease Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Infectious Disease Drugs Revenue & Forecasts
        6.2.1 By Region - Global Infectious Disease Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Infectious Disease Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Infectious Disease Drugs Revenue, 2017-2028
        6.3.2 US Infectious Disease Drugs Market Size, 2017-2028
        6.3.3 Canada Infectious Disease Drugs Market Size, 2017-2028
        6.3.4 Mexico Infectious Disease Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Infectious Disease Drugs Revenue, 2017-2028
        6.4.2 Germany Infectious Disease Drugs Market Size, 2017-2028
        6.4.3 France Infectious Disease Drugs Market Size, 2017-2028
        6.4.4 U.K. Infectious Disease Drugs Market Size, 2017-2028
        6.4.5 Italy Infectious Disease Drugs Market Size, 2017-2028
        6.4.6 Russia Infectious Disease Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Infectious Disease Drugs Market Size, 2017-2028
        6.4.8 Benelux Infectious Disease Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Infectious Disease Drugs Revenue, 2017-2028
        6.5.2 China Infectious Disease Drugs Market Size, 2017-2028
        6.5.3 Japan Infectious Disease Drugs Market Size, 2017-2028
        6.5.4 South Korea Infectious Disease Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Infectious Disease Drugs Market Size, 2017-2028
        6.5.6 India Infectious Disease Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Infectious Disease Drugs Revenue, 2017-2028
        6.6.2 Brazil Infectious Disease Drugs Market Size, 2017-2028
        6.6.3 Argentina Infectious Disease Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Infectious Disease Drugs Revenue, 2017-2028
        6.7.2 Turkey Infectious Disease Drugs Market Size, 2017-2028
        6.7.3 Israel Infectious Disease Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Infectious Disease Drugs Market Size, 2017-2028
        6.7.5 UAE Infectious Disease Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 GlaxoSmithKline
        7.1.1 GlaxoSmithKline Corporate Summary
        7.1.2 GlaxoSmithKline Business Overview
        7.1.3 GlaxoSmithKline Infectious Disease Drugs Major Product Offerings
        7.1.4 GlaxoSmithKline Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.1.5 GlaxoSmithKline Key News
    7.2 Gilead Sciences
        7.2.1 Gilead Sciences Corporate Summary
        7.2.2 Gilead Sciences Business Overview
        7.2.3 Gilead Sciences Infectious Disease Drugs Major Product Offerings
        7.2.4 Gilead Sciences Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.2.5 Gilead Sciences Key News
    7.3 Merck & Co.
        7.3.1 Merck & Co. Corporate Summary
        7.3.2 Merck & Co. Business Overview
        7.3.3 Merck & Co. Infectious Disease Drugs Major Product Offerings
        7.3.4 Merck & Co. Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.3.5 Merck & Co. Key News
    7.4 Pfizer
        7.4.1 Pfizer Corporate Summary
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer Infectious Disease Drugs Major Product Offerings
        7.4.4 Pfizer Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.4.5 Pfizer Key News
    7.5 Sanofi
        7.5.1 Sanofi Corporate Summary
        7.5.2 Sanofi Business Overview
        7.5.3 Sanofi Infectious Disease Drugs Major Product Offerings
        7.5.4 Sanofi Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.5.5 Sanofi Key News
    7.6 AbbVie
        7.6.1 AbbVie Corporate Summary
        7.6.2 AbbVie Business Overview
        7.6.3 AbbVie Infectious Disease Drugs Major Product Offerings
        7.6.4 AbbVie Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.6.5 AbbVie Key News
    7.7 Shire
        7.7.1 Shire Corporate Summary
        7.7.2 Shire Business Overview
        7.7.3 Shire Infectious Disease Drugs Major Product Offerings
        7.7.4 Shire Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.7.5 Shire Key News
    7.8 Grifols
        7.8.1 Grifols Corporate Summary
        7.8.2 Grifols Business Overview
        7.8.3 Grifols Infectious Disease Drugs Major Product Offerings
        7.8.4 Grifols Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.8.5 Grifols Key News
    7.9 Johnson & Johnson
        7.9.1 Johnson & Johnson Corporate Summary
        7.9.2 Johnson & Johnson Business Overview
        7.9.3 Johnson & Johnson Infectious Disease Drugs Major Product Offerings
        7.9.4 Johnson & Johnson Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.9.5 Johnson & Johnson Key News
    7.10 Protein Sciences
        7.10.1 Protein Sciences Corporate Summary
        7.10.2 Protein Sciences Business Overview
        7.10.3 Protein Sciences Infectious Disease Drugs Major Product Offerings
        7.10.4 Protein Sciences Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.10.5 Protein Sciences Key News
    7.11 AstraZeneca
        7.11.1 AstraZeneca Corporate Summary
        7.11.2 AstraZeneca Business Overview
        7.11.3 AstraZeneca Infectious Disease Drugs Major Product Offerings
        7.11.4 AstraZeneca Infectious Disease Drugs Revenue in Global Market (2017-2022)
        7.11.5 AstraZeneca Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Infectious Disease Drugs Market Opportunities & Trends in Global Market
    Table 2. Infectious Disease Drugs Market Drivers in Global Market
    Table 3. Infectious Disease Drugs Market Restraints in Global Market
    Table 4. Key Players of Infectious Disease Drugs in Global Market
    Table 5. Top Infectious Disease Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Infectious Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Infectious Disease Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Infectious Disease Drugs Product Type
    Table 9. List of Global Tier 1 Infectious Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Infectious Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Infectious Disease Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Infectious Disease Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Infectious Disease Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Infectious Disease Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Infectious Disease Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Infectious Disease Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Infectious Disease Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Infectious Disease Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Infectious Disease Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Infectious Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Infectious Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. GlaxoSmithKline Corporate Summary
    Table 31. GlaxoSmithKline Infectious Disease Drugs Product Offerings
    Table 32. GlaxoSmithKline Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Gilead Sciences Corporate Summary
    Table 34. Gilead Sciences Infectious Disease Drugs Product Offerings
    Table 35. Gilead Sciences Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Merck & Co. Corporate Summary
    Table 37. Merck & Co. Infectious Disease Drugs Product Offerings
    Table 38. Merck & Co. Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer Corporate Summary
    Table 40. Pfizer Infectious Disease Drugs Product Offerings
    Table 41. Pfizer Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Sanofi Corporate Summary
    Table 43. Sanofi Infectious Disease Drugs Product Offerings
    Table 44. Sanofi Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. AbbVie Corporate Summary
    Table 46. AbbVie Infectious Disease Drugs Product Offerings
    Table 47. AbbVie Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Shire Corporate Summary
    Table 49. Shire Infectious Disease Drugs Product Offerings
    Table 50. Shire Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Grifols Corporate Summary
    Table 52. Grifols Infectious Disease Drugs Product Offerings
    Table 53. Grifols Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Johnson & Johnson Corporate Summary
    Table 55. Johnson & Johnson Infectious Disease Drugs Product Offerings
    Table 56. Johnson & Johnson Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Protein Sciences Corporate Summary
    Table 58. Protein Sciences Infectious Disease Drugs Product Offerings
    Table 59. Protein Sciences Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. AstraZeneca Corporate Summary
    Table 61. AstraZeneca Infectious Disease Drugs Product Offerings
    Table 62. AstraZeneca Infectious Disease Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Infectious Disease Drugs Segment by Type in 2021
    Figure 2. Infectious Disease Drugs Segment by Application in 2021
    Figure 3. Global Infectious Disease Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Infectious Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Infectious Disease Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Infectious Disease Drugs Revenue in 2021
    Figure 8. By Type - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Infectious Disease Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Infectious Disease Drugs Revenue Market Share, 2017-2028
    Figure 12. US Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Infectious Disease Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Infectious Disease Drugs Revenue Market Share, 2017-2028
    Figure 24. China Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Infectious Disease Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Infectious Disease Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Infectious Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. GlaxoSmithKline Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Gilead Sciences Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Merck & Co. Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Sanofi Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AbbVie Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Shire Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Grifols Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Johnson & Johnson Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Protein Sciences Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. AstraZeneca Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Infectious Disease Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Infectious Disease Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Infectious Disease Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Etch Process Market

Etch Process is used in microfabrication to chemically remove layers from the surface of a wafer  ... Read More